JPS6348849B2 - - Google Patents

Info

Publication number
JPS6348849B2
JPS6348849B2 JP54156458A JP15645879A JPS6348849B2 JP S6348849 B2 JPS6348849 B2 JP S6348849B2 JP 54156458 A JP54156458 A JP 54156458A JP 15645879 A JP15645879 A JP 15645879A JP S6348849 B2 JPS6348849 B2 JP S6348849B2
Authority
JP
Japan
Prior art keywords
sulfate
zinc
pharmaceutically acceptable
polyoxyethylene sorbitan
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54156458A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5579321A (en
Inventor
Ruukasu Bofumiru
Uiizendanga Waruta
Haintsu Shumitsuto Rutsupin Kaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of JPS5579321A publication Critical patent/JPS5579321A/ja
Publication of JPS6348849B2 publication Critical patent/JPS6348849B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP15645879A 1978-12-04 1979-12-04 Medical composition for local administration Granted JPS5579321A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1236078 1978-12-04

Publications (2)

Publication Number Publication Date
JPS5579321A JPS5579321A (en) 1980-06-14
JPS6348849B2 true JPS6348849B2 (enExample) 1988-09-30

Family

ID=4382297

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15645879A Granted JPS5579321A (en) 1978-12-04 1979-12-04 Medical composition for local administration

Country Status (9)

Country Link
EP (1) EP0012115A1 (enExample)
JP (1) JPS5579321A (enExample)
AU (1) AU531882B2 (enExample)
CA (1) CA1146859A (enExample)
IT (1) IT1164070B (enExample)
LU (1) LU81944A1 (enExample)
NZ (1) NZ192294A (enExample)
SE (1) SE448604B (enExample)
ZA (1) ZA796549B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080682B (en) * 1980-07-30 1984-03-28 Ciba Geigy Ag Antiherpetically active lipstick
DE3273138D1 (en) * 1981-06-02 1986-10-16 Eupan Corp Eustatic composition for nonspecifically facilitating and amplifying the generalized homeostatic regulation and maintenance, compensation and repair in living organisms
AU556817B2 (en) * 1982-02-03 1986-11-20 Efamol Limited Topical application of a lithium salt and dihomo-alpha- linolenic acid
FR2548023B1 (fr) * 1983-06-16 1987-06-26 Victoria State Medicament veterinaire et solution de bain de pieds pour le traitement du pietin des ovins
US4661354A (en) * 1984-06-21 1987-04-28 Finnerty Edmund F Topical treatment of herpes simplex with a zinc sulfate-camphor water solution
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
WO1988007060A1 (en) * 1987-03-19 1988-09-22 Arthropharm Pty. Limited Anti-inflammatory compounds and compositions
EP0285357A3 (en) * 1987-03-31 1989-10-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Control of retroviruses
EP0402078A3 (en) * 1989-06-06 1991-07-31 Patrick Daniel Kelly Sexual lubricants containing zinc as an anti-viral agent
US5624675A (en) * 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
DE4200499A1 (de) * 1992-01-10 1993-07-15 Bode Chemie Gmbh & Co Desinfektionsmittel
JP2571190Y2 (ja) * 1992-10-31 1998-05-13 株式会社ミヨシ パワーショベル等の油圧回路
GB9521805D0 (en) * 1995-10-25 1996-01-03 Cortecs Ltd Solubilisation methods
US6475526B1 (en) * 2001-06-05 2002-11-05 Jeffrey B. Smith Zinc containing compositions for anti-viral use
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
EP2283805A1 (en) 2009-07-28 2011-02-16 Sirvis BV Compositions comprising a zinc containing compound dissolved in a hydrophobic phase
JP6139506B2 (ja) * 2011-04-04 2017-05-31 コロプラスト アクティーゼルスカブ 接着パッチ
EP3791884A1 (en) 2019-09-16 2021-03-17 Oskar Bunz Combination of heparin and magnesium salt for the treatment of viral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77562A1 (de) * 1977-06-17 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von neuen pharmazeutischen praeparaten
JPS6225126A (ja) * 1985-07-25 1987-02-03 Matsushita Electric Works Ltd 付加型イミド樹脂積層板

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug

Also Published As

Publication number Publication date
ZA796549B (en) 1980-11-26
AU5337979A (en) 1980-06-12
LU81944A1 (de) 1980-07-01
CA1146859A (en) 1983-05-24
IT1164070B (it) 1987-04-08
JPS5579321A (en) 1980-06-14
NZ192294A (en) 1982-05-31
EP0012115A1 (de) 1980-06-11
SE448604B (sv) 1987-03-09
SE7909952L (sv) 1980-06-05
IT7950953A0 (it) 1979-11-30
AU531882B2 (en) 1983-09-08

Similar Documents

Publication Publication Date Title
JPS6225126B2 (enExample)
JPS6348849B2 (enExample)
CA1199273A (en) Anti-inflammatory composition
US4797392A (en) Use of anorectal compositions
PT1510213E (pt) Sistemas de melhoramento de penetração e reduzida irritação incluíndo testosterona
US4039664A (en) Topical griseofulvin composition and method
UA76415C2 (uk) Застосування похідних бігуаніду для отримання лікарського препарату з ефектом загоєння ран
JP3504279B2 (ja) 皮膚の萎縮軽減剤、およびその使用法
CN1149992C (zh) 活性化合物高度释放的抗真菌凝胶
US8642053B2 (en) Potentiated topical composition
RU2325912C1 (ru) Фармацевтическая композиция противовоспалительного и антимикробного действия в форме мази на гидрофобной основе для лечения кожных заболеваний (варианты)
AU674411B2 (en) Compositions for the treatment of inflammatory proliferative skin disease and their use
CA2074216A1 (en) Topical anti-fungal agents having anti-inflammatory activity
AU2002339819A1 (en) Potentiated topical composition
ALMEYDA et al. Double blind controlled study of treatment of atopic eczema with a preparation of hydrocortisone in a new drug delivery system versus betamethasone 17‐valerate
JPS63145217A (ja) 経皮投与組成物
PT97139A (pt) Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente citotoxico como ingrediente activo e uma mistura veicular que comprenede agentes que aceleram a penetracao atraves da pele, nomeadamente, um alcool e propilenoglicol ou polietilenoglicol
DE69717961T2 (de) Verwendung eines flavonoid enthaltenden extraktes der planze euphorbia prostrata zur herstellung eines medikamentes zur behandlung von anoraktalen oder kolonbeschwerden
CS366289A2 (en) Method of stable aqueous suspeoemulsions production
EP0480996A1 (en) Benzophenanthridine alkaloids for topical acne treatment
KR930000050B1 (ko) 항균제 겔 배합물
JP3259972B2 (ja) トルナフタート含有抗真菌剤
JPS6317825A (ja) 創傷治癒促進剤
JPH05117141A (ja) 副腎エキス含有消炎鎮痛ゲル剤
CN115624520A (zh) 一种地奥司明乳膏剂和应用